Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
Naito A, Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Tabata M, Miyakawa J, Suzuki M, Nishimatsu H, Enomoto Y, Takahashi S, Okaneya T, Yamada D, Tachikawa T, Minowada S, Fujimura T, Fukuhara H, Kume H, Homma Y. Naito A, et al. Among authors: nagase y. World J Urol. 2017 Jan;35(1):97-103. doi: 10.1007/s00345-016-1846-y. Epub 2016 May 14. World J Urol. 2017. PMID: 27180266
Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Uemura Y, Fujimura T, Fukuhara H, Kume H, Homma Y. Taguchi S, et al. Among authors: nagase y. Int J Urol. 2015 Jul;22(7):638-43. doi: 10.1111/iju.12766. Epub 2015 Apr 22. Int J Urol. 2015. PMID: 25903328
Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.
Taguchi S, Nakagawa T, Uemura Y, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Fujimura T, Fukuhara H, Kume H, Homma Y. Taguchi S, et al. Among authors: nagase y. World J Urol. 2016 Feb;34(2):163-71. doi: 10.1007/s00345-015-1631-3. Epub 2015 Jul 2. World J Urol. 2016. PMID: 26135306
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Nakagawa T, et al. Among authors: nagase y. Urol Oncol. 2017 Jul;35(7):457.e15-457.e21. doi: 10.1016/j.urolonc.2016.12.010. Epub 2017 Jan 16. Urol Oncol. 2017. PMID: 28110856
Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?
Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S, Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Nakagawa T, et al. Among authors: nagase y. Ann Surg Oncol. 2017 Sep;24(9):2794-2800. doi: 10.1245/s10434-017-5970-8. Epub 2017 Jul 7. Ann Surg Oncol. 2017. PMID: 28687875
Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. Matsumoto A, et al. Among authors: nagase y. World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28. World J Urol. 2018. PMID: 29185045
Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).
Taguchi S, Kawai T, Nakagawa T, Miyakawa J, Kishitani K, Sugimoto K, Nakamura Y, Kamei J, Obinata D, Yamaguchi K, Kaneko T, Yoshida K, Yamamoto S, Kakutani S, Kanazawa K, Sugihara Y, Tokunaga M, Matsumoto A, Uemura Y, Akiyama Y, Yamada Y, Sato Y, Yamada D, Enomoto Y, Nishimatsu H, Ishikawa A, Tanaka Y, Nagase Y, Fujimura T, Fukuhara H, Takahashi S, Kume H. Taguchi S, et al. Among authors: nagase y. Int J Urol. 2022 Dec;29(12):1462-1469. doi: 10.1111/iju.15014. Epub 2022 Aug 22. Int J Urol. 2022. PMID: 35996761 Free PMC article.
[Evaluation of advanced bladder tumor].
Nagase Y, Moriyama N, Kurimoto S, Tanaka Y, Oshi M, Honma Y, Tajima A, Higashihara E, Aso Y. Nagase Y, et al. Nihon Hinyokika Gakkai Zasshi. 1995 Apr;86(4):933-9. doi: 10.5980/jpnjurol1989.86.933. Nihon Hinyokika Gakkai Zasshi. 1995. PMID: 7776563 Free article. Japanese.
274 results